Deciphera Pharmaceuticals (DCPH) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free DCPH Stock Alerts $14.58 +0.40 (+2.82%) (As of 01:39 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Significant Increase in Short Interestmarketbeat.com - April 17 at 11:16 AMDeciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forumbusinesswire.com - April 9 at 7:00 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Stock Price Down 3.6%marketbeat.com - April 8 at 3:24 PMSG Americas Securities LLC Lowers Stake in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - April 3 at 4:18 AMNovo Nordisk strikes deal worth up to $1.1 billion to expand cardio businessmsn.com - March 25 at 10:40 AMCompanies Like Deciphera Pharmaceuticals (NASDAQ:DCPH) Are In A Position To Invest In Growthfinance.yahoo.com - March 24 at 2:38 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Given New $16.00 Price Target at JPMorgan Chase & Co.marketbeat.com - March 21 at 2:52 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Shares Down 5.1% marketbeat.com - March 18 at 12:44 PMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Sold by Jacobs Levy Equity Management Inc.marketbeat.com - March 13 at 6:56 AMHsbc Holdings PLC Has $237,000 Stock Holdings in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - March 10 at 4:43 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Reaches New 1-Year High at $17.73marketbeat.com - March 1 at 2:41 PMBraidwell LP Sells 310,198 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - March 1 at 10:18 AMQ1 2024 EPS Estimates for Deciphera Pharmaceuticals, Inc. Decreased by Zacks Research (NASDAQ:DCPH)marketbeat.com - February 29 at 8:22 AMDeerfield Management Company L.P. Series C Purchases 190,580 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - February 28 at 2:11 PMAnalysts Issue Forecasts for Deciphera Pharmaceuticals, Inc.'s FY2026 Earnings (NASDAQ:DCPH)marketbeat.com - February 28 at 9:57 AMDeciphera Pharmaceuticals to Participate in Upcoming Investor Conferencesbusinesswire.com - February 27 at 7:00 AMHealthcare of Ontario Pension Plan Trust Fund Trims Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - February 26 at 6:57 AMDeutsche Bank AG Has $3.24 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - February 24 at 5:00 AMRafferty Asset Management LLC Sells 91,351 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - February 23 at 5:47 AMWall Street Analysts Believe Deciphera Pharmaceuticals, Inc. (DCPH) Could Rally 59.63%: Here's is How to Tradefinance.yahoo.com - February 12 at 3:11 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Given New $23.00 Price Target at Stifel Nicolausmarketbeat.com - February 8 at 8:26 AMAnalysts Are Updating Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Estimates After Its Annual Resultsfinance.yahoo.com - February 8 at 8:19 AMLeerink Partnrs Comments on Deciphera Pharmaceuticals, Inc.'s FY2023 Earnings (NASDAQ:DCPH)marketbeat.com - February 8 at 7:06 AMBuy Rating Reaffirmed for Deciphera Pharmaceuticals on Strong Q4 Performance and Promising Drug Prospectsmarkets.businessinsider.com - February 7 at 5:17 PMAnalysts Are Bullish on Top Healthcare Stocks: Deciphera Pharmaceuticals (DCPH), ACADIA Pharmaceuticals (ACAD)markets.businessinsider.com - February 7 at 12:17 PMDeciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beatfinance.yahoo.com - February 7 at 12:17 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Releases Earnings Results, Beats Expectations By $0.04 EPSmarketbeat.com - February 7 at 9:50 AMDeciphera Pharmaceuticals: Sustained Growth and Market Expansion Drive Buy Ratingmarkets.businessinsider.com - February 6 at 8:32 PMDeciphera Pharmaceuticals: Strong Buy Rating on Robust Financials and Promising Pipelinemarkets.businessinsider.com - February 6 at 8:32 PMDeciphera Pharmaceuticals, Inc. Q4 Loss beats estimatesmarkets.businessinsider.com - February 6 at 10:31 AMDeciphera Pharmaceuticals Q4 2023 Earnings Previewmsn.com - February 5 at 1:31 PMSeattle woman who returned Costco couch after 2.5 years goes viral, sparks ethics debatenz.finance.yahoo.com - February 2 at 7:18 PMDeciphera Pharmaceuticals (DCPH) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - February 2 at 9:35 AMDeciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024finance.yahoo.com - February 1 at 6:07 PMNurix Therapeutics, Inc. (NRIX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Releasefinance.yahoo.com - February 1 at 1:07 PMDeciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conferencefinance.yahoo.com - February 1 at 8:07 AMZacks Research Equities Analysts Increase Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - February 1 at 6:13 AMDeciphera Pharmaceuticals LLC (DCPH)uk.investing.com - January 31 at 8:24 AMStrong week for Deciphera Pharmaceuticals (NASDAQ:DCPH) shareholders doesn't alleviate pain of three-year lossfinance.yahoo.com - January 29 at 9:32 AMPanagora Asset Management Inc. Takes Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - January 22 at 5:45 AMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) SVP Sells $23,499.28 in Stockmarketbeat.com - January 18 at 7:24 PMDeciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposiumfinance.yahoo.com - January 18 at 1:40 PMGENESIS Pharma Announces an Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize RIPRETINIB in 14 EU Markets in Central and Eastern Europebusinesswire.com - January 12 at 7:48 AMDeciphera Pharmaceuticals: A Strong Buy on Impressive Qinlock Sales and Promising Vimseltinib Prospectsmarkets.businessinsider.com - January 11 at 10:36 AMDeciphera: Upside Potential For The Patient Investorseekingalpha.com - January 9 at 4:37 AMDeciphera Pharmaceuticals: Moving The Needle Where It Countsseekingalpha.com - January 8 at 8:23 AMDeciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical ...businesswire.com - January 5 at 7:53 AMDeciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18finance.yahoo.com - January 5 at 7:53 AMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Short Interest Updatemarketbeat.com - January 1 at 12:16 PMSunesis Advisors LLC Invests $1.23 Million in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - December 30 at 10:16 AM Get Deciphera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide DCPH Media Mentions By Week DCPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DCPH News Sentiment▼1.000.33▲Average Medical News Sentiment DCPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DCPH Articles This Week▼12▲DCPH Articles Average Week Get Deciphera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PIRS News Today COLL News Today GMTX News Today ABCL News Today MIRM News Today LGND News Today SYRE News Today MNKD News Today PCRX News Today XNCR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DCPH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceDonald Trump Just Predicted "America's Greatest Defeat"Birch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
